EU Launches Fast-Track Monitoring Of Crucial COVID-19 Drug Shortages
A new system for monitoring the availability of medicines for treating COVID-19 patients will allow EU-level coordinated actions to address supply shortages in the best way.
You may also be interested in...
As COVID-19-related drug shortages continue to persist in the EU, regulators explore the possibility of drawing lessons from existing models that member states use to estimate national demand for medicines.
A public health advocacy group in the EU has issued tangible recommendations to address the perennial problem of drug shortages in the region.
Supporting convergence, allowing greater regulatory flexibility and avoiding drug shortages were among key topics discussed by global regulators at the first of a series of bi-weekly exchanges organized by the International Coalition of Medicines Regulatory Authorities.